Evolution Wealth Advisors, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Evolution Wealth Advisors, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2021$5,000
-64.3%
277
-67.5%
0.00%
-66.7%
Q2 2021$14,000
-26.3%
852
-19.4%
0.00%
-25.0%
Q1 2021$19,0000.0%1,0570.0%0.00%0.0%
Q4 2020$19,000
-24.0%
1,057
-23.5%
0.00%
-42.9%
Q3 2020$25,000
-13.8%
1,381
-15.2%
0.01%
-30.0%
Q2 2020$29,000
+11.5%
1,628
-3.7%
0.01%
-9.1%
Q1 2020$26,000
-46.9%
1,691
-32.5%
0.01%
-8.3%
Q4 2019$49,000
+1125.0%
2,506
+948.5%
0.01%
+500.0%
Q3 2019$4,000
-91.3%
239
-90.8%
0.00%
-90.0%
Q2 2019$46,0002,6110.02%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders